The Melio Difference

Melio is designed to be the first rapid, comprehensive bloodborne pathogen testing platform that can identify 99% of the most common pathogens — without the use of a blood culture.

Melio will deliver precise results in hours, bypassing the days-long wait of traditional tests.

Direct from Blood Detection

Melio’s platform is designed to enable direct-from-blood diagnostic testing for specific identification of intact pathogens.

Pathogen-Agnostic Detection

Melio can detect a wide range of pathogens without the need for targeted probes — breaking the ‘one pathogen, one probe’ paradigm. Whether the pathogen is widely known or newly discovered, the solution will identify it with ease.

Expand to New Pathogens at the Speed of Software

In addition to constantly expanding the list of pathogens identified, our AI-backed technology is also quick to recognize new, emerging pathogens. This allows for rare and opportunistic pathogens to be added to the database, as well as rapid rollout of new detection capabilities at hospitals globally, necessitating no hardware or reagent changes, just software updates.

Roadmap of Detectable Pathogens

Our revolutionary blood diagnostic solution will identify the most prevalent and problematic clinical pathogens. Here is a look at our ever-growing list of pathogens, currently available in our database.